Viewing Study NCT07419295


Ignite Creation Date: 2026-03-26 @ 3:14 PM
Ignite Modification Date: 2026-03-31 @ 5:58 AM
Study NCT ID: NCT07419295
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-02-19
First Post: 2026-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module